ASCO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO 2022 Conference Coverage

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

Playback speed

10 seconds

ASCO 2022 Treatment-Free Remission in CML Patients Following the Discontinuation of Tyrosine Kinase Inhibitors

By ASCO 2022 Conference Coverage FEATURING Fadi Haddad

143 views

June 28, 2022

Comments 0

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Leukemia

Lecture Summary - ASCO 2022 Efficacy & Safety Results From the Phase…

ASCO 2022 Conference Coverage

J. Cortés

22 views

ASCO 2022 Efficacy & Safety Results From the Phase 3 ASCEMBL Study o…

ASCO 2022 Conference Coverage

J. Cortés

269 views

Lecture Summary - ASCO 2022 on Overall Survival by IDH2 Mutant Allel…

ASCO 2022 Conference Coverage

S. De Botton

13 views

ASCO 2022 on Overall Survival by IDH2 Mutant Allele (R140 or R172) i…

ASCO 2022 Conference Coverage

S. De Botton

19 views

ASCO 2022 Updated Results From a Phase II Study of mini-HCVD + Ino +…

ASCO 2022 Conference Coverage

W. Macaron

76 views

ASCO 2022 Treatment-Free Remission in CML Patients Following the Dis…

ASCO 2022 Conference Coverage

F. Haddad

143 views

Lecture Summary - ASCO 2022 Treatment-Free Remission in CML Patients…

ASCO 2022 Conference Coverage

F. Haddad

13 views

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase…

ASCO 2022 Conference Coverage

R. Cassaday

20 views

ASCO 2022 Updates on the Evolution of Asparaginase in the Management…

ASCO 2022 Conference Coverage

R. Cassaday

359 views

Lecture Summary - ASCO 2022 on Leveraging AML Genomics Across the Th…

ASCO 2022 Conference Coverage

G. Mannis

12 views

ASCO 2022 on a Phase 1b Study of Blinatumomab With the Anti-Programm…

ASCO 2022 Conference Coverage

C. Papayannidis

15 views

Lecture Summary - ASCO 2022 on a Phase 1b Study of Blinatumomab With…

ASCO 2022 Conference Coverage

C. Papayannidis

9 views

ASCO 2022 on a Phase II Study of Hyper-CVAD With Sequential Blina +/…

ASCO 2022 Conference Coverage

N. Short

25 views

Lecture Summary - ASCO 2022 on a Phase II Study of Hyper-CVAD With S…

ASCO 2022 Conference Coverage

N. Short

14 views

ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastrointestinal, Liver,…

ASCO 2022 Conference Coverage

J. Cortés

83 views

Lecture Summary - ASCO 2022 Bosutinib in Newly Diagnosed CML: Gastro…

ASCO 2022 Conference Coverage

J. Cortés

13 views

ASCO 2022 Efficacy and Safety of Bosutinib in Later-Line Patients Wi…

ASCO 2022 Conference Coverage

C. Gambacorti-Passerini

50 views